BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 24485975)

  • 1. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration.
    Ohbayashi Y; Nakai F; Iwasaki A; Ogawa T; Yamamoto Y; Nishiyama Y; Miyake M
    Odontology; 2017 Jul; 105(3):382-390. PubMed ID: 27770302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
    Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
    Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bisphosphonate on the remodeling of different irregular bones in mice.
    Su J; Feng M; Han W; Zhao H
    J Oral Pathol Med; 2015 Sep; 44(8):638-48. PubMed ID: 25370709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of osteonecrosis of jaws after bisphosphonates therapy for bone metastasis of breast cancer].
    Guo YX; Wang DC; Wang Y; Peng X; Mao C; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):80-3. PubMed ID: 26885913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
    Nastro E; Musolino C; Allegra A; Oteri G; Cicciù M; Alonci A; Quartarone E; Alati C; De Ponte FS
    Acta Haematol; 2007; 117(3):181-7. PubMed ID: 17164581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A
    Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
    Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A; Atlas J
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
    Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM
    Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.
    Bantis A; Zissimopoulos A; Sountoulides P; Kalaitzis C; Giannakopoulos S; Deftereos S; Tsakaldimis G; Thomaidis V; Touloupidis S
    Tumori; 2011; 97(4):479-83. PubMed ID: 21989437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
    Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
    Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.